HeartSciences Inc. today announced the appointment of Dr. Girish Nadkarni, Dr. Joshua Lampert, and Dr. Akhil Vaid to its Scientific Advisory Board. These distinguished leaders bring extensive expertise at the intersection of cardiology, artificial intelligence, and data-driven healthcare. Their addition underscores HeartSciences' commitment to advancing its AI-ECG technology.
Dr. Nadkarni is the Director of the Charles Bronfman Institute for Personalized Medicine at Mount Sinai and has pioneered AI-based approaches, co-founding companies with FDA-cleared AI solutions. Dr. Lampert is the Medical Director of Machine Learning for Mount Sinai Fuster Heart Hospital, focusing on novel machine learning tools for patient care. Dr. Vaid, an Assistant Professor at Mount Sinai, specializes in applying machine learning and AI in cardiology, including developing AI models for detecting cardiac dysfunction.
CEO Andrew Simpson stated that their guidance will be instrumental in advancing the company's mission to transform cardiac care through early detection and intervention. These appointments are expected to strengthen HeartSciences' position in leading the evolution of ECG technology into an essential diagnostic tool for precision medicine.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.